Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) was the target of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 111,907 shares, an increase of 1,048.7% from the August 31st total of 9,742 shares. Based on an average daily trading volume, of 81,381 shares, the days-to-cover ratio is currently 1.4 days.
Ono Pharmaceutical Stock Down 2.5%
OPHLY stock traded down $0.13 during trading on Thursday, hitting $5.14. 57,185 shares of the company traded hands, compared to its average volume of 35,325. Ono Pharmaceutical has a 1 year low of $3.71 and a 1 year high of $5.75. The stock’s 50-day simple moving average is $5.04 and its 200 day simple moving average is $4.99.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its principal focus areas include oncology, immunology, neurology and other specialty diseases, with an emphasis on innovative treatments for conditions with significant unmet medical needs.
The company is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used in the treatment of multiple types of cancer.
See Also
- Five stocks we like better than Ono Pharmaceutical
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
